Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ramsay Health CareASX:RHC +2.94%82 3-Year EPS without NRI Growth Rate is 5.40% as of Jun. 2026, which is 60% below its 10-year median of 13.60. GuruFocus rates ASX:RHC with a GF Score™ of 82/100 and a GF Value™ of A$41.02 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 506 Healthcare Providers & Services companies, Ramsay Health Care ranks worse than 63.04% on this metric.
During the past 12 months, Ramsay Health Care's average EPS without NRI Growth Rate was 11.80% per year.
During the past 3 years, the average EPS without NRI Growth Rate was 5.40% per year.
During the past 5 years, the average EPS without NRI Growth Rate was -4.30% per year.
During the past 10 years, the average EPS without NRI Growth Rate was -7.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Ramsay Health Care was 68.00% per year. The lowest was -25.20% per year. And the median was 13.60% per year.
Ramsay Health Care (ASX:RHC) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Ramsay Health Care 3-Year EPS without NRI Growth Rate Related Terms
ASX:RHC vs HCA, THC, DVA: 3-Year EPS without NRI Growth Rate Comparison
For the Medical Care Facilities subindustry, Ramsay Health Care's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ramsay Health Care 3-Year EPS without NRI Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ramsay Health Care's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Ramsay Health Care's 3-Year EPS without NRI Growth Rate falls into.
Ramsay Health Care 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 5.40% mean?
Ramsay Health Care (ASX:RHC) has a 3-Year EPS without NRI Growth Rate of 5.40% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Ramsay Health Care and its competitors. This is 60% below median its historical median of 13.60. According to the industry distribution chart, Ramsay Health Care ranks #319 out of 506 companies in the Healthcare Providers & Services industry, placing it in the top 63%.
Is Ramsay Health Care's 3-Year EPS without NRI Growth Rate too high?
Ramsay Health Care's current 3-Year EPS without NRI Growth Rate of 5.40% is 60% below median its 10-year median of 13.60. The Healthcare Providers & Services industry median 3-Year EPS without NRI Growth Rate is 11.00. Ramsay Health Care's value of 5.40% is 50.9% below this industry median. Based on the distribution chart, Ramsay Health Care ranks #319 out of 506 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Ramsay Health Care has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ramsay Health Care's 3-Year EPS without NRI Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ramsay Health Care ranks #319 out of 506 companies for 3-Year EPS without NRI Growth Rate. This places Ramsay Health Care in the lower half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 11.00. Ramsay Health Care's value of 5.40% is 50.9% below this benchmark. While the company's 10-year median is 13.60 vs. the industry median of 11.00, Ramsay Health Care has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EPS without NRI Growth Rate among Healthcare Providers & Services companies is 11.00, based on 506 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ramsay Health Care's current 3-Year EPS without NRI Growth Rate of 5.40% is 50.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Ramsay Health Care and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EPS without NRI Growth Rate is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ramsay Health Care's current 3-Year EPS without NRI Growth Rate is 5.40%, which is 60% below median its own 10-year median of 13.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramsay Health Care stock overvalued right now?
Based on GuruFocus' analysis, Ramsay Health Care (ASX:RHC) is currently considered Modestly Overvalued. The stock's GF Value™ is A$41.02, compared to a current price of A$51.53 — trading 25.6% above its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 5.40%, which is 60% below median its 10-year median of 13.60 and 50.9% below the Healthcare Providers & Services industry median of 11.00. Ramsay Health Care's overall GF Score™ is 82/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Ramsay Health Care (ASX:RHC), the current 3-Year EPS without NRI Growth Rate is 5.40% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramsay Health Care (ASX:RHC) Overvalued in 2026?
Based on GuruFocus' analysis, Ramsay Health Care stock appears to be overvalued.
The current stock price of A$51.53 is trading 25.6% above its estimated GF Value™ of A$41.02.
GuruFocus considers Ramsay Health Care to be Modestly Overvalued.
Key valuation signals for ASX:RHC:
3-Year EPS without NRI Growth Rate: 5.40% (60% below median its 10-year median of 13.60)
GF Value™: A$41.02 vs. price of A$51.53 (25.6% above fair value)
Industry Position: 50.9% below the Healthcare Providers & Services median (#319 of 506)
No single metric tells the full story. See the ASX:RHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramsay Health Care is one of the largest private healthcare providers in the world, with more than 500 sites across about eight countries. The key markets in which it operates are Australia, France, the UK, and Sweden. It is the largest private hospital group in each of these markets except for the UK, where it is the largest independent supplier to the NHS. Ramsay Santé, which operates the European regions other than the UK, is a 53%-owned subsidiary of Ramsay Health Care. The company typically earns about two-thirds of consolidated earnings in Australia. Ramsay Health Care undertakes both private and publicly funded healthcare.
82GF Score
Get the complete analysis for ASX:RHC
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:RHC has been successfully added to your 
